| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.9M | +14.0% |
| R&D Expense | $303.6M | +59.0% |
| SG&A Expense | $86.2M | +59.1% |
| Operating Income | -$378.9M | -60.8% |
| Income Tax | $0 | — |
| Net Income | -$322.3M | -51.9% |
| EPS (Basic) | -$2.89 | +0.7% |
| EPS (Diluted) | -$2.89 | +0.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $219.9M | +18.8% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $1.54B | +152.3% |
| Total Assets | $1.56B | +148.8% |
| Current Liabilities | $98.0M | +21.5% |
| Total Liabilities | $138.9M | +8.7% |
| Stockholders' Equity | $1.42B | +184.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$300.9M | -152.7% |
| Capital Expenditures | $7.1M | +67.1% |
| Investing Cash Flow | -$854.2M | -556.7% |
| Financing Cash Flow | $1.19B | +1170.3% |
| Free Cash Flow | -$307.9M | -149.8% |